Levesque A

No ORCID on file · 4 papers in corpus · active 2022-2026

Study types

  • other 2
  • article 1
  • rct 1

Condition tags

  • endometriosis 3
  • chronic_pelvic_pain 3
  • dysmenorrhea 1
  • irritable_bowel_syndrome 1
other 2026
Consensus-based management of endometriosis-associated pelvic pain: Results of a French Delphi study
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2026.103167

OBJECTIVE: To develop best practice guidelines under the auspices of the CNGOF (National college of French Gynaecologist Obstetrician) and Convergences PP (Convergences in Pelviperineal Pain) for the management of endometriosis-associated p…

article 2025
[Clinical practice guidelines for pelvic pain associated with endometriosis. A consensus-based approach by CNGOF & Convergences PP]
Gynecologie, obstetrique, fertilite & senologie ·doi:10.1016/j.gofs.2025.06.003

OBJECTIVE: To develop best practice guidelines under the auspices of the CNGOF and Convergences PP for the management of pain associated with endometriosis. METHOD: We organised a literature review and a formal expert consensus. A multidis…

other 2023
Evaluation of a scoring system for the detection of central sensitization among women with chronic pelvic pain
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2023.07.044

BACKGROUND: Central sensitization is frequently associated with chronic pelvic pain and requires specific management. The pain is described as hypersensitivity to an innocuous stimulus that is both widespread and persistent. However, no stu…

rct 2022
Transcutaneous electrical neurostimulation relieves primary dysmenorrhea: A randomized, double-blind clinical study versus placebo
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie ·doi:10.1016/j.purol.2022.01.005

INTRODUCTION: This randomized, crossover, double-blind, controlled trial evaluates the efficacy and safety of a preprogrammed transcutaneous electrical nerve stimulation (TENS) device versus placebo (SHAM) in women with primary dysmenorrhea…